Return On Assets in % of Moleculin Biotech, Inc. from 2016 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Moleculin Biotech, Inc. quarterly/annual Return On Assets history and change rate from 2016 to Q3 2025.
  • Moleculin Biotech, Inc. Return On Assets for the quarter ending 30 Sep 2025 was -257 %, a 155% decline year-over-year.
  • Moleculin Biotech, Inc. annual Return On Assets for 2024 was -90 %, a 32.9% decline from 2023.
  • Moleculin Biotech, Inc. annual Return On Assets for 2023 was -67.7 %, a 60.2% decline from 2022.
  • Moleculin Biotech, Inc. annual Return On Assets for 2022 was -42.2 %, a 143% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Moleculin Biotech, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -257 -157 -155% 01 Jul 2025 30 Sep 2025
Q2 2025 -159 -74.9 -88.7% 01 Apr 2025 30 Jun 2025
Q1 2025 -97.8 -25.1 -34.6% 01 Jan 2025 31 Mar 2025
Q4 2024 -90 -22.3 -32.9% 01 Oct 2024 31 Dec 2024
Q3 2024 -101 -46.9 -87.1% 01 Jul 2024 30 Sep 2024
Q2 2024 -84.4 -31.4 -59.3% 01 Apr 2024 30 Jun 2024
Q1 2024 -72.7 -24 -49.2% 01 Jan 2024 31 Mar 2024
Q4 2023 -67.7 -25.5 -60.2% 01 Oct 2023 31 Dec 2023
Q3 2023 -53.9 -20.6 -61.9% 01 Jul 2023 30 Sep 2023
Q2 2023 -53 -27.3 -106% 01 Apr 2023 30 Jun 2023
Q1 2023 -48.7 -27.5 -129% 01 Jan 2023 31 Mar 2023
Q4 2022 -42.2 -24.9 -143% 01 Oct 2022 31 Dec 2022
Q3 2022 -33.3 -13.1 -64.7% 01 Jul 2022 30 Sep 2022
Q2 2022 -25.7 -2.07 -8.77% 01 Apr 2022 30 Jun 2022
Q1 2022 -21.2 +22.7 +51.7% 01 Jan 2022 31 Mar 2022
Q4 2021 -17.4 +44.1 +71.7% 01 Oct 2021 31 Dec 2021
Q3 2021 -20.2 +47.6 +70.2% 01 Jul 2021 30 Sep 2021
Q2 2021 -23.6 +44.9 +65.5% 01 Apr 2021 30 Jun 2021
Q1 2021 -44 -7.23 -19.7% 01 Jan 2021 31 Mar 2021
Q4 2020 -61.4 -12.9 -26.5% 01 Oct 2020 31 Dec 2020
Q3 2020 -67.8 -20.5 -43.4% 01 Jul 2020 30 Sep 2020
Q2 2020 -68.5 -25.4 -59% 01 Apr 2020 30 Jun 2020
Q1 2020 -36.7 +28.5 +43.6% 01 Jan 2020 31 Mar 2020
Q4 2019 -48.6 +4.54 +8.55% 01 Oct 2019 31 Dec 2019
Q3 2019 -47.3 +7.65 +13.9% 01 Jul 2019 30 Sep 2019
Q2 2019 -43.1 +15.7 +26.8% 01 Apr 2019 30 Jun 2019
Q1 2019 -65.2 -12.3 -23.3% 01 Jan 2019 31 Mar 2019
Q4 2018 -53.1 -5.07 -10.6% 01 Oct 2018 31 Dec 2018
Q3 2018 -54.9 -14 -34.2% 01 Jul 2018 30 Sep 2018
Q2 2018 -58.8 -23.8 -68.1% 01 Apr 2018 30 Jun 2018
Q1 2018 -52.9 -31.4 -146% 01 Jan 2018 31 Mar 2018
Q4 2017 -48 -18.4 -62% 01 Oct 2017 31 Dec 2017
Q3 2017 -40.9 01 Jul 2017 30 Sep 2017
Q2 2017 -35 01 Apr 2017 30 Jun 2017
Q1 2017 -21.5 01 Jan 2017 31 Mar 2017
Q4 2016 -29.6 01 Oct 2016 31 Dec 2016

Moleculin Biotech, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -90 -22.3 -32.9% 01 Jan 2024 31 Dec 2024
2023 -67.7 -25.5 -60.2% 01 Jan 2023 31 Dec 2023
2022 -42.2 -24.9 -143% 01 Jan 2022 31 Dec 2022
2021 -17.4 +44.1 +71.7% 01 Jan 2021 31 Dec 2021
2020 -61.4 -12.9 -26.5% 01 Jan 2020 31 Dec 2020
2019 -48.6 +4.54 +8.55% 01 Jan 2019 31 Dec 2019
2018 -53.1 -5.07 -10.6% 01 Jan 2018 31 Dec 2018
2017 -48 -18.4 -62% 01 Jan 2017 31 Dec 2017
2016 -29.6 01 Jan 2016 31 Dec 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.